Cargando…
Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1–12 dosage
BACKGROUND: One of the causes of Parkinson's disease is mutations in the PARK2 gene. Deletions and duplications of single exons or exon groups account for a large proportion of the gene mutations. Direct detection of these mutations can be used for the diagnosis of Parkinson's disease. MET...
Autores principales: | Shadrina, Maria I, Semenova, Elena V, Slominsky, Petr A, Bagyeva, Gulbahar H, Illarioshkin, Sergei N, Ivanova-Smolenskaia, Irina I, Limborska, Svetlana A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1810516/ https://www.ncbi.nlm.nih.gov/pubmed/17324265 http://dx.doi.org/10.1186/1471-2350-8-6 |
Ejemplares similares
-
Involvement of Endocytosis and Alternative Splicing in the Formation of the Pathological Process in the Early Stages of Parkinson's Disease
por: Alieva, Anelya Kh., et al.
Publicado: (2014) -
Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
por: Volkova, Anastasiya, et al.
Publicado: (2016) -
ITPR1 gene p.Val1553Met mutation in Russian family with mild Spinocerebellar ataxia
por: Shadrina, M. I., et al.
Publicado: (2016) -
Potential Biomarkers of the Earliest Clinical Stages of Parkinson's Disease
por: Alieva, Anelya Kh., et al.
Publicado: (2015) -
Modeling Parkinson’s Disease: Not Only Rodents?
por: Shadrina, Maria, et al.
Publicado: (2021)